India’s stakes in the Global Pandemic Agreement
Published: · Updated:
Source: The Hindu, 8 October 2026
Summary
- India made official remarks at the UN High Level Meeting (UN HLM) on pandemic prevention, preparedness and response (PPPR) in New York in September 2026. The meeting dealt with a Political Declaration that sits within the emerging global legal regime led by the WHO Pandemic Agreement (PA).
- The article argues that India should help finalise the Pathogen Access and Benefit-Sharing (PABS) annex. It should also lead the Global South in the post-PABS phase, using partnerships, global groupings and domestic regulatory strength.
Key facts for Prelims
- WHO Pandemic Agreement was adopted by the World Health Assembly on 20 May 2025 (resolution WHA78.1). It is legally binding.
- PABS = Pathogen Access and Benefit-Sharing system. It is Article 12 of the Agreement and will be an annex.
- Article 31: the Agreement opens for signature only after the WHA adopts the PABS annex. It enters into force 30 days after 60 ratifications.
- IGWG (Intergovernmental Working Group) was established to negotiate the PABS annex.
- UNGA High-Level Meeting on PPPR: first in 2023, second on 25 September 2026.
- The Pandemic Agreement aligns with the amended International Health Regulations (2005).
- One Health: integrated approach to human, animal and environmental health.
- Global Initiative on Digital Health was launched during India's G20 presidency in 2023.
- "Partners for Multilateralism" was launched in 2026 by the EU, with co-sponsors Australia, Barbados, Brazil, Canada, India and Kenya.
- Terms: HICs/LICs/LMICs (high-, low-, lower-middle-income countries); API (Active Pharmaceutical Ingredient).
Data and details
- The PA was adopted by 124 member-states in 2025, including India. No country voted against and 11 abstained.
- The PA is not yet open for ratification because the PABS annex is still under negotiation.
- US position: it rejected the Declaration, calling PABS and the WHO's role in declaring pandemics a challenge to its national interests.
- Fault lines:
- African countries did not consent to monitoring the human-animal-environment interface without significant funding, which the Global North did not guarantee.
- Global North countries did not want binding targets on technology transfer and similar provisions.
- Negotiators disputed whether a global treaty can set binding One Health targets without funding for weak health systems, whether national pandemic regulations can be harmonised, and whether private manufacturers can be required to share vaccines in real time at affordable prices.
- India's HLM stance: it succeeded in enshrining the multilateral components of the PA within the principle of national sovereignty. It stressed equitable access to drugs, vaccines and therapeutics, creation of global public goods (such as digital infrastructure), and respect for national sovereignty and the primacy of member-states. Its line was "Global Solidarity must be demonstrated through action".
- India's Health Secretary told the HLM that digital health infrastructure, laboratory networks and One Health interventions are valuable as global public goods.
- India's structural position: "pharmacy of the world", one of the largest vaccine manufacturers by volume. But patents for vaccines it makes are held by global pharma companies, and it is import-dependent for APIs. It needs Global North technology for high-grade PPE and medical devices.
- The H20 summit (a health and development G7/G20 partnership) will take place at the end of 2027 under UK's G20 leadership, with pandemic preparedness as a core agenda.
- The article is based on a forthcoming CSEP (Centre for Social and Economic Progress) working paper.
Static–dynamic linkage
- Treaty-making and global health governance involve a tension between sovereignty and collective action. Pandemics need shared surveillance and equitable access to medicines, but states resist binding obligations on technology transfer, funding or oversight.
- India sits at the intersection. It is a large vaccine manufacturer, an importer of Active Pharmaceutical Ingredients (APIs), and a voice of the Global South. It therefore seeks both equitable access and sovereignty safeguards.
- The article also illustrates the concept of "global public goods" (digital health infrastructure, laboratory networks, One Health) as India's soft-power contribution. It links to the principle of South–South cooperation.
Syllabus mapping: GS2 – IR: International institutions (WHO, UN), bilateral/multilateral groupings; GS2 – Health; GS3 – S&T/biotechnology and IPR; Prelims – S&T: Health
Background primer
WHO Pandemic Agreement (PA) and PABS system
- What it is:
- The world's first Pandemic Agreement, a legally binding international instrument designed to make the world safer and more equitable in the face of future pandemics.
- Founded:
- The negotiating body (INB) was established in December 2021 at a special session of the World Health Assembly. The WHA adopted the Agreement on 20 May 2025. It aims to address weaknesses exposed by COVID-19 and strengthen cooperation and equity in future prevention, preparedness and response.
- Members:
- it is open to WHO Member States. The adopting resolution (WHA78.1) records that adoption does not prejudice each State's sovereign prerogative to consider the Agreement under its own constitutional processes. The Agreement enters into force 30 days after 60 ratifications.
- Mandate:
- The PABS annex is meant to ensure, on equal footing, rapid sharing of pathogens with pandemic potential and fair, equitable sharing of benefits from their use, including vaccines, diagnostics and therapeutics. PABS is described in Article 12, and an Intergovernmental Working Group (IGWG) was set up to negotiate the annex.
- Why it matters:
- equity and solidarity, so that low- and middle-income countries are not left behind in access to medical countermeasures (the COVID-19 lesson the article invokes).
UN High-Level Meeting on PPPR / Political Declaration
- What it is:
- The UNGA's second High-level Meeting on PPPR, following the first in 2023.
- Mandate:
- The meeting was to approve a concise, action-oriented political declaration agreed in advance by consensus, for adoption by the General Assembly. The declaration highlights a One Health approach linking human, animal and environmental health.
Additional context
- Negotiations on the PABS annex continued at the eighth IGWG meeting (14–18 September 2026, hybrid format) ahead of the HLM.
- The original plan was for the annex to go to the 79th World Health Assembly (May 2026). In March 2026, Member States agreed to extend negotiations, which resumed from 27 April to 1 May. On 1 May they agreed more time was needed. The WHA then decided that the IGWG would continue its work, with the outcome going to the Eightieth WHA in May 2027 or to a special session of the Assembly in 2026. On 13 November 2026, WHO reported that Member States had reiterated their commitment to finalise the PABS annex for the WHA in May 2027.
- The HLM did not end in consensus. The declaration was due to be approved by consensus on 25 September, but objections from the United States and a few other States pushed it back to the General Assembly. The General Assembly adopted it later by 153 votes to three (Argentina, Israel, US), with two abstentions (New Zealand and Paraguay). WHO welcomed the adoption on 12 October 2026.
- India's plenary statement at the HLM (automatic-speech-recognition UN transcript, not an official record): India described a whole-of-government, whole-of-society, all-hazards approach to preparedness. It said preparedness must be embedded in national health systems and domestic financing, and that international support should complement national responsibility. It also said digital public infrastructure should be recognised as a global public good.
Mains dimensions
- Sovereignty vs solidarity: the PA negotiation turned on how far binding global commitments can go. India balances equity demands with insistence on national sovereignty.
- North–South divide: the funding-versus-obligation bargain (One Health monitoring in Africa vs technology-transfer targets in the North) explains why PABS is stuck. India can act as a bridge.
- India's three options:
- Technical partnerships with Global South countries (One Health, surveillance, health workforce) to build trust and a "store" of operational solutions to sovereignty problems.
- Leveraging groupings: H20 under the UK's 2027 G20 presidency, the G20 Global Initiative on Digital Health, and Partners for Multilateralism.
- Getting domestic regulation of access to biological material and benefit distribution right, since global leadership rests on domestic strengths.
- Self-interest: India's vaccine capacity depends on patents held abroad and on imported APIs. An equitable PABS regime and technology access serve its manufacturing and public-health goals.
- South–South role: sharing digital health infrastructure, laboratory networks and One Health tools as global public goods.
- Contrast with the US: it opposed PABS and WHO's role in declaring pandemics. This shows the risk of fragmentation in the regime even before ratification.
- Absent: the PA cannot yet be ratified, so its "first-of-its-kind regime" currently operates without the annex that gives it practical content.
Possible Mains question
**GS2, 15 marks:** "The WHO Pandemic Agreement cannot be ratified until the PABS annex is adopted. Analyse the Global North–South fault lines in the negotiations and suggest how India can balance its sovereignty concerns with leadership of the Global South."
Related topics
- WHO structure and the World Health Assembly; International Health Regulations (2005); COVID-19 vaccine inequity (COVAX)
- Treaty-making and ratification in India (Article 253, Union List entry on treaties)
- TRIPS flexibilities, compulsory licensing, IPR and API dependence; PLI schemes for pharma/medical devices
- G20 presidency outcomes; South–South Cooperation; One Health and zoonoses; Digital public infrastructure as global public good
Topics: GS2Sci & Tech
All current affairs of 8 October 2026 → · UPSC Current Affairs